BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Kristine M. Ball Joins Relypsa, Inc. as Senior Vice President, Chief Financial Officer


12/11/2012 11:11:18 AM

SANTA CLARA, Calif.--(BUSINESS WIRE)--Relypsa, Inc., a clinical-stage biopharmaceutical company, announced today the appointment of Kristine M. Ball to the position of Senior Vice President and Chief Financial Officer. She will be responsible for overseeing Relypsa’s finance, accounting and investor relations functions. “It is with great pleasure that we welcome Kristine to Relypsa during this important time in the company’s evolution,” stated Gerrit Klaerner, Ph.D., President of Relypsa. "The next 18 months will be an exciting time for Relypsa filled with many key value driving milestones, including completion of our phase 3 clinical program for patiromer and filing a New Drug Application with the FDA shortly thereafter. With Kristine’s extensive strategic and financial experience, she will bring additional strength and leadership to our management team as we drive towards these milestones and progress toward becoming a commercial company.”

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->